ComplyRx

Antibody-drug conjugates · Live ClinicalTrials.gov data

Sacituzumab govitecan (Trodelvy) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 sacituzumab govitecan (Trodelvy) trials on ClinicalTrials.gov by enrolment, 7 of them actively recruiting. The next phase 3 primary completion among them is expected Jul 2028. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

7

Phase 3 trials

7

Actively recruiting

Jul 2028

Next phase 3 primary completion

5,545

Participants across trials

Gilead Sciences

Lead sponsor by trial count

sacituzumab govitecan (16)13 active2017–2034
sacituzumab govitecan
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingActive, not recruitingNot yet recruitingCompleted
'17
'19
'21
'23
'25
'27
'29
'31
'33
sacituzumab govitecan
ASCENTP3
TROPiCS-02P3
InCITeP2
Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBCP2
TROPiCS-04P3
Scalp Cooling in MBCP2
ASCENT-03P3
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)P2
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast CancerP2
A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast CancerP2
ARIANP3
A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBCP2
OASISP2
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial CancerP3
ctDNA-guided Treatment Decision-makingP2
ADAPT-TN-IVP3

Upcoming readouts

11 ahead · sacituzumab govitecan

Select a trial to load its full ClinicalTrials.gov record.

Key sacituzumab govitecan trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT06524544A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standar…Phase 3RecruitingDec 2030
NCT06431633ARIAN: Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to t…Phase 3RecruitingNov 2031
NCT05382299ASCENT-03: Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Prev…Phase 3Active, not recruitingJul 2028
NCT07178730ADAPT-TN-IV: NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinic…Phase 3Not yet recruitingMar 2033
NCT02574455ASCENT: Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negati…Phase 3CompletedMar 2020
NCT03901339TROPiCS-02: Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With …Phase 3CompletedOct 2023
NCT04527991TROPiCS-04: Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Uroth…Phase 3CompletedJul 2025
NCT06878625A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-n…Phase 2RecruitingJun 2027
NCT05601440Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastati…Phase 2RecruitingDec 2027
NCT07394218ctDNA-guided Treatment Decision-makingPhase 2RecruitingMar 2028
NCT04986579Scalp Cooling in MBCPhase 2RecruitingJun 2028
NCT07259226OASIS: Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Bi…Phase 2RecruitingNov 2030

Track sacituzumab govitecan with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track sacituzumab govitecan

Related drug pipelines

Compare sacituzumab govitecan vs trastuzumab deruxtecanCompare sacituzumab govitecan vs datopotamab deruxtecan

FAQ

How many clinical trials are running for sacituzumab govitecan?
ClinicalTrials.gov lists more than 16 phase 2–4 sacituzumab govitecan trials. This page tracks the 16 largest by enrolment: 9 phase 2, 7 phase 3, and 0 phase 4 among them, with 7 actively recruiting. Updated daily.
Are there clinical trials for Trodelvy?
Trodelvy is the brand name for sacituzumab govitecan, so sacituzumab govitecan trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 sacituzumab govitecan trials. This page tracks the 16 largest by enrolment: 9 phase 2, 7 phase 3, and 0 phase 4 among them, with 7 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare sacituzumab govitecan against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.